{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T17:29:19Z","timestamp":1792862959467,"version":"4.5.0"},"publisher-location":"Cham","reference-count":166,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319553290","type":"print"},{"value":"9783319553306","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-55330-6_11","type":"book-chapter","created":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T11:33:41Z","timestamp":1495884821000},"page":"203-226","source":"Crossref","is-referenced-by-count":63,"title":["Mitochondria and Cardiac Hypertrophy"],"prefix":"10.1007","author":[{"given":"Heberty di Tarso Fernandes","family":"Facundo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Eli","family":"Brainard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Rodrigo de Lemos","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Maria Brito","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,28]]},"reference":[{"issue":"1","key":"11_CR1","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics \u2013 2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6\u2013245.","journal-title":"Circulation"},{"issue":"11","key":"11_CR2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/81321","volume":"6","author":"N Frey","year":"2000","unstructured":"Frey N, McKinsey TA, Olson EN. Decoding calcium signals involved in cardiac growth and function. Nat Med. 2000;6(11):1221\u20137.","journal-title":"Nat Med"},{"issue":"2","key":"11_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","volume":"93","author":"JD Molkentin","year":"1998","unstructured":"Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93(2):215\u201328.","journal-title":"Cell"},{"issue":"10","key":"11_CR4","doi-asserted-by":"crossref","first-page":"H2122","DOI":"10.1152\/ajpheart.00775.2011","volume":"302","author":"HT Facundo","year":"2012","unstructured":"Facundo HT, Brainard RE, Watson LJ, Ngoh GA, Hamid T, Prabhu SD, et al. O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy. Am J Physiol Heart Circ Physiol. 2012;302(10):H2122\u201330.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"11_CR5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0735-1097(01)01826-5","volume":"39","author":"M Date","year":"2002","unstructured":"Date M, Morita T, Yamashita N, Nishida K, Yamaguchi O, Higuchi Y, et al. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol. 2002;39(5):907\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"4 Pt 2","key":"11_CR6","first-page":"H1280","volume":"266","author":"AK Dhalla","year":"1994","unstructured":"Dhalla AK, Singal PK. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Phys. 1994;266(4 Pt 2):H1280\u20135.","journal-title":"Am J Phys"},{"issue":"4","key":"11_CR7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/hc0402.102863","volume":"105","author":"S Hirotani","year":"2002","unstructured":"Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, et al. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation. 2002;105(4):509\u201315.","journal-title":"Circulation"},{"issue":"5","key":"11_CR8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/hh1701.096615","volume":"89","author":"DR Pimentel","year":"2001","unstructured":"Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, et al. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res. 2001;89(5):453\u201360.","journal-title":"Circ Res"},{"issue":"8","key":"11_CR9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/01.CIR.98.8.794","volume":"98","author":"K Nakamura","year":"1998","unstructured":"Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, et al. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation. 1998;98(8):794\u20139.","journal-title":"Circulation"},{"issue":"3","key":"11_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2007.06.044","volume":"130","author":"NS Rajasekaran","year":"2007","unstructured":"Rajasekaran NS, Connell P, Christians ES, Yan L-J, Taylor RP, Orosz A, et al. Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell. 2007;130(3):427\u201339.","journal-title":"Cell"},{"issue":"7","key":"11_CR11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0022-2828(92)93381-S","volume":"24","author":"E Barth","year":"1992","unstructured":"Barth E, St\u00e4mmler G, Speiser B, Schaper J. Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. J Mol Cell Cardiol. 1992;24(7):669\u201381.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"11_CR12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","volume":"113","author":"SC Kolwicz","year":"2013","unstructured":"Kolwicz SC, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res. 2013;113(5):603\u201316.","journal-title":"Circ Res"},{"issue":"5","key":"11_CR13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10741-012-9346-7","volume":"18","author":"M Osterholt","year":"2013","unstructured":"Osterholt M, Nguyen TD, Schwarzer M, Doenst T. Alterations in mitochondrial function in cardiac hypertrophy and heart failure. Heart Fail Rev. 2013;18(5):645\u201356.","journal-title":"Heart Fail Rev"},{"issue":"4","key":"11_CR14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","volume":"116","author":"H Ashrafian","year":"2007","unstructured":"Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation. 2007;116(4):434\u201348.","journal-title":"Circulation"},{"issue":"4","key":"11_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Executive summary: heart disease and stroke statistics \u2013 2016 update: a report from the American Heart Association. Circulation. 2016;133(4):447\u201354.","journal-title":"Circulation"},{"issue":"5","key":"11_CR16","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0735-1097(86)80236-4","volume":"7","author":"P Anversa","year":"1986","unstructured":"Anversa P, Ricci R, Olivetti G. Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. J Am Coll Cardiol. 1986;7(5):1140\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"11_CR17","doi-asserted-by":"crossref","first-page":"S678","DOI":"10.1016\/S0003-4975(02)04692-1","volume":"75","author":"I Friehs","year":"2003","unstructured":"Friehs I, del Nido PJ. Increased susceptibility of hypertrophied hearts to ischemic injury. Ann Thorac Surg. 2003;75(2):S678\u201384.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"11_CR18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pcad.2006.02.001","volume":"48","author":"AH Gradman","year":"2006","unstructured":"Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis. 2006;48(5):326\u201341.","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"11_CR19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/713773607","volume":"10","author":"RA Boer De","year":"2003","unstructured":"De Boer RA, Pinto YM, Van Veldhuisen DJ. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation. 2003;10(2):113\u201326.","journal-title":"Microcirculation"},{"key":"11_CR20","doi-asserted-by":"crossref","unstructured":"Santulli G, Xie W, Reiken SR, Marks AR. Mitochondrial calcium overload is a key determinant in heart failure. Proc Natl Acad Sci U S A. 2015;112:11389\u201394.","DOI":"10.1073\/pnas.1513047112"},{"issue":"16","key":"11_CR21","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1089\/ars.2012.4729","volume":"18","author":"TR Figueira","year":"2013","unstructured":"Figueira TR, Barros MH, Camargo AA, Castilho RF, Ferreira JCB, Kowaltowski AJ, et al. Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. Antioxid Redox Signal. 2013;18(16):2029\u201374.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"11_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","volume":"552","author":"JF Turrens","year":"2003","unstructured":"Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552(2):335\u201344.","journal-title":"J Physiol"},{"issue":"9","key":"11_CR23","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.freeradbiomed.2009.02.008","volume":"46","author":"EB Tahara","year":"2009","unstructured":"Tahara EB, Navarete FDT, Kowaltowski AJ. Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic Biol Med. 2009;46(9):1283\u201397.","journal-title":"Free Radic Biol Med"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2013.04.001","volume":"61C","author":"NR Madamanchi","year":"2013","unstructured":"Madamanchi NR, Runge MS. Redox signaling in cardiovascular health and disease. Free Radic Biol Med. 2013;61C:473\u2013501.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"11_CR25","doi-asserted-by":"crossref","first-page":"H1227","DOI":"10.1152\/ajpheart.01162.2006","volume":"292","author":"C Berndt","year":"2007","unstructured":"Berndt C, Lillig CH, Holmgren A. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol. 2007;292(3):H1227\u201336.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"11_CR26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0735-1097(96)00140-4","volume":"28","author":"AK Dhalla","year":"1996","unstructured":"Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol. 1996;28(2):506\u201314.","journal-title":"J Am Coll Cardiol"},{"issue":"27","key":"11_CR27","doi-asserted-by":"crossref","first-page":"19323","DOI":"10.1074\/jbc.274.27.19323","volume":"274","author":"Z Xie","year":"1999","unstructured":"Xie Z, Kometiani P, Liu J, Li J, Shapiro JI, Askari A. Intracellular reactive oxygen species mediate the linkage of Na+\/K\u00b1 ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem. 1999;274(27):19323\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"11_CR28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCRESAHA.112.279760","volume":"112","author":"S Matsushima","year":"2013","unstructured":"Matsushima S, Kuroda J, Ago T, Zhai P, Park JY, Xie L-H, et al. Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ Res. 2013;112(4):651\u201363.","journal-title":"Circ Res"},{"issue":"6","key":"11_CR29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0022-2828(03)00084-1","volume":"35","author":"SH Kwon","year":"2003","unstructured":"Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS. H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol. 2003;35(6):615\u201321.","journal-title":"J Mol Cell Cardiol"},{"issue":"5407","key":"11_CR30","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.283.5407.1488","volume":"283","author":"M Saraste","year":"1999","unstructured":"Saraste M. Oxidative phosphorylation at the fin de si\u00e8cle. Science. 1999;283(5407):1488\u201393.","journal-title":"Science"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.bi.54.070185.005055","volume":"54","author":"Y Hatefi","year":"1985","unstructured":"Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem. 1985;54:1015\u201369.","journal-title":"Annu Rev Biochem"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fphys.2012.00332","volume":"3","author":"M Kindo","year":"2012","unstructured":"Kindo M, Gerelli S, Bouitbir J, Charles A-L, Zoll J, Hoang Minh T, et al. Pressure overload-induced mild cardiac hypertrophy reduces left ventricular transmural differences in mitochondrial respiratory chain activity and increases oxidative stress. Front Physiol. 2012;3:332.","journal-title":"Front Physiol"},{"issue":"3","key":"11_CR33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0034-5288(02)00189-3","volume":"74","author":"CS Lin","year":"2003","unstructured":"Lin CS, Sun YL, Liu CY. Structural and biochemical evidence of mitochondrial depletion in pigs with hypertrophic cardiomyopathy. Res Vet Sci. 2003;74(3):219\u201326.","journal-title":"Res Vet Sci"},{"issue":"1","key":"11_CR34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/abbi.1997.0489","volume":"350","author":"LK Kwong","year":"1998","unstructured":"Kwong LK, Sohal RS. Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria. Arch Biochem Biophys. 1998;350(1):118\u201326.","journal-title":"Arch Biochem Biophys"},{"issue":"47","key":"11_CR35","doi-asserted-by":"crossref","first-page":"44784","DOI":"10.1074\/jbc.M207217200","volume":"277","author":"J St-Pierre","year":"2002","unstructured":"St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem. 2002;277(47):44784\u201390.","journal-title":"J Biol Chem"},{"issue":"5\u20136","key":"11_CR36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bbabio.2006.03.013","volume":"1757","author":"VG Grivennikova","year":"2006","unstructured":"Grivennikova VG, Vinogradov AD. Generation of superoxide by the mitochondrial complex I. Biochim Biophys Acta. 2006;1757(5\u20136):553\u201361.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"11_CR37","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jtcvs.2009.08.060","volume":"139","author":"ER Griffiths","year":"2010","unstructured":"Griffiths ER, Friehs I, Scherr E, Poutias D, McGowan FX, Del Nido PJ. Electron transport chain dysfunction in neonatal pressure-overload hypertrophy precedes cardiomyocyte apoptosis independent of oxidative stress. J Thorac Cardiovasc Surg. 2010;139(6):1609\u201317.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"11_CR38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/cvr\/cvr274","volume":"93","author":"D-F Dai","year":"2012","unstructured":"Dai D-F, Hsieh EJ, Liu Y, Chen T, Beyer RP, Chin MT, et al. Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress. Cardiovasc Res. 2012;93(1):79\u201388.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"11_CR39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/cvr\/cvp344","volume":"85","author":"H Bugger","year":"2010","unstructured":"Bugger H, Schwarzer M, Chen D, Schrepper A, Amorim PA, Schoepe M, et al. Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc Res. 2010;85(2):376\u201384.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"11_CR40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cvr\/cvn184","volume":"80","author":"MG Rosca","year":"2008","unstructured":"Rosca MG, Vazquez EJ, Kerner J, Parland W, Chandler MP, Stanley W, et al. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res. 2008;80(1):30\u20139.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"11_CR41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrm2959","volume":"11","author":"O Schmidt","year":"2010","unstructured":"Schmidt O, Pfanner N, Meisinger C. Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol. 2010;11(9):655\u201367.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"11_CR42","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cell.2009.08.005","volume":"138","author":"A Chacinska","year":"2009","unstructured":"Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N. Importing mitochondrial proteins: machineries and mechanisms. PubMed \u2013 NCBICell. 2009;138(4):628\u201344.","journal-title":"Cell"},{"issue":"8","key":"11_CR43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/cr.2014.94","volume":"24","author":"J Li","year":"2014","unstructured":"Li J, Qi M, Li C, Shi D, Zhang D, Xie D, et al. Tom70 serves as a molecular switch to determine pathological cardiac hypertrophy. Cell Res. 2014;24(8):977\u201393.","journal-title":"Cell Res"},{"key":"11_CR44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1302.017","volume":"1015","author":"H Taegtmeyer","year":"2004","unstructured":"Taegtmeyer H, Golfman L, Sharma S, Razeghi P, van Arsdall M. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann N Y Acad Sci. 2004;1015:202\u201313.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"11_CR45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/ajplegacy.1970.218.1.153","volume":"218","author":"SP Bishop","year":"1970","unstructured":"Bishop SP, Altschuld RA. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Phys. 1970;218(1):153\u20139.","journal-title":"Am J Phys"},{"issue":"5","key":"11_CR46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.HYP.11.5.416","volume":"11","author":"H Taegtmeyer","year":"1988","unstructured":"Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension. 1988;11(5):416\u201326.","journal-title":"Hypertension"},{"issue":"4","key":"11_CR47","doi-asserted-by":"crossref","first-page":"H1345","DOI":"10.1152\/ajpheart.2000.278.4.H1345","volume":"278","author":"C Korvald","year":"2000","unstructured":"Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol. 2000;278(4):H1345\u201351.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6 Pt 2","key":"11_CR48","first-page":"H2876","volume":"273","author":"J Ren","year":"1997","unstructured":"Ren J, Gintant GA, Miller RE, Davidoff AJ. High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner. Am J Phys. 1997;273(6 Pt 2):H2876\u201383.","journal-title":"Am J Phys"},{"issue":"5","key":"11_CR49","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.HYP.0000144292.69599.0c","volume":"44","author":"L Nascimben","year":"2004","unstructured":"Nascimben L, Ingwall JS, Lorell BH, Pinz I, Schultz V, Tornheim K, et al. Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertens (Dallas, Tex 1979). 2004;44(5):662\u20137.","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"5","key":"11_CR50","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.CIR.92.5.1274","volume":"92","author":"J Zhang","year":"1995","unstructured":"Zhang J, Duncker DJ, Ya X, Zhang Y, Pavek T, Wei H, Merkle H, U\u011furbil K, From AHBR. Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2- deoxyglucose uptake. Circulation. 1995;92(5):1274\u201383.","journal-title":"Circulation"},{"issue":"3","key":"11_CR51","doi-asserted-by":"crossref","first-page":"E487","DOI":"10.1152\/ajpendo.2000.279.3.E487","volume":"279","author":"MF Allard","year":"2000","unstructured":"Allard MF, Wambolt RB, Longnus SL, Grist M, Lydell CP, Parsons HL, et al. Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin. Am J Physiol Endocrinol Metab. 2000;279(3):E487\u201393.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4 Pt 2","key":"11_CR52","first-page":"H1615","volume":"272","author":"Z Alaoui-Talibi El","year":"1997","unstructured":"El Alaoui-Talibi Z, Guendouz A, Moravec M, Moravec J. Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine. Am J Phys. 1997;272(4 Pt 2):H1615\u201324. 1997;272:H1615\u201324","journal-title":"Am J Phys"},{"issue":"5","key":"11_CR53","doi-asserted-by":"crossref","first-page":"E1039","DOI":"10.1152\/ajpendo.00507.2001","volume":"282","author":"HS Leong","year":"2002","unstructured":"Leong HS, Grist M, Parsons H, Wambolt RB, Lopaschuk GD, Brownsey R, et al. Accelerated rates of glycolysis in the hypertrophied heart: are they a methodological artifact? Am J Physiol Endocrinol Metab. 2002;282(5):E1039\u201345.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"15","key":"11_CR54","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/CIRCULATIONAHA.106.668665","volume":"115","author":"N Sorokina","year":"2007","unstructured":"Sorokina N, O\u2019Donnell JM, McKinney RD, Pound KM, Woldegiorgis G, LaNoue KF, et al. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts. Circulation. 2007;115(15):2033\u201341.","journal-title":"Circulation"},{"issue":"3","key":"11_CR55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cvr\/cvp414","volume":"86","author":"T Doenst","year":"2010","unstructured":"Doenst T, Pytel G, Schrepper A, Amorim P, F\u00e4rber G, Shingu Y, et al. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload. Cardiovasc Res. 2010;86(3):461\u201370.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"11_CR56","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0008-6363(01)00560-0","volume":"53","author":"CP Lydell","year":"2002","unstructured":"Lydell CP, Chan A, Wambolt RB, Sambandam N, Parsons H, Bondy GP, et al. Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts. Cardiovasc Res. 2002;53(4):841\u201351.","journal-title":"Cardiovasc Res"},{"issue":"1\u20132","key":"11_CR57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11010-008-9711-y","volume":"311","author":"A Akki","year":"2008","unstructured":"Akki A, Smith K, Seymour A-ML. Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation. Mol Cell Biochem. 2008;311(1\u20132):215\u201324.","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"11_CR58","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1006\/jmcc.1994.1155","volume":"26","author":"ME Christe","year":"1994","unstructured":"Christe ME, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol. 1994;26(10):1371\u20135.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"11_CR59","doi-asserted-by":"crossref","first-page":"H2098","DOI":"10.1152\/ajpheart.00471.2008","volume":"295","author":"K Qanud","year":"2008","unstructured":"Qanud K, Mamdani M, Pepe M, Khairallah RJ, Gravel J, Lei B, et al. Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure. Am J Physiol Heart Circ Physiol. 2008;295(5):H2098\u2013105.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"11_CR60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1203\/00006450-199508000-00015","volume":"38","author":"TD Scholz","year":"1995","unstructured":"Scholz TD, Koppenhafer SL. Reducing equivalent shuttles in developing porcine myocardium: enhanced capacity in the newborn heart. Pediatr Res. 1995;38(2):221\u20137.","journal-title":"Pediatr Res"},{"issue":"12","key":"11_CR61","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1006\/jmcc.2000.1257","volume":"32","author":"BE Rupert","year":"2000","unstructured":"Rupert BE, Segar JL, Schutte BC, Scholz T. Metabolic adaptation of the hypertrophied heart: role of the malate\/aspartate and alpha-glycerophosphate shuttles. J Mol Cell Cardiol. 2000;32(12):2287\u201397. 2000;32(12):2287\u201397","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"11_CR62","doi-asserted-by":"crossref","first-page":"C1880","DOI":"10.1152\/ajpcell.00576.2006","volume":"292","author":"ED Lewandowski","year":"2007","unstructured":"Lewandowski ED, O\u2019donnell JM, Scholz TD, Sorokina N, Buttrick PM. Recruitment of NADH shuttling in pressure-overloaded and hypertrophic rat hearts. Am J Phys Cell Phys. 2007;292(5):C1880\u20136.","journal-title":"Am J Phys Cell Phys"},{"issue":"6","key":"11_CR63","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/CIRCRESAHA.108.189951","volume":"104","author":"KM Pound","year":"2009","unstructured":"Pound KM, Sorokina N, Ballal K, Berkich DA, Fasano M, Lanoue KF, et al. Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy. Circ Res. 2009;104(6):805\u201312.","journal-title":"Circ Res"},{"issue":"2 Pt 2","key":"11_CR64","first-page":"H742","volume":"267","author":"MF Allard","year":"1994","unstructured":"Allard MF, Sch\u00f6nekess BO, Henning SL, English DR, Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Phys. 1994;267(2 Pt 2):H742\u201350.","journal-title":"Am J Phys"},{"issue":"3","key":"11_CR65","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1152\/ajpendo.00093.2009","volume":"297","author":"L Hue","year":"2009","unstructured":"Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab. 2009;297(3):E578\u201391.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"11_CR66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1015380609464","volume":"7","author":"N Sambandam","year":"2002","unstructured":"Sambandam N, Lopaschuk GD, Brownsey RW, Allard MF. Energy metabolism in the hypertrophied heart. Heart Fail Rev. 2002;7(2):161\u201373.","journal-title":"Heart Fail Rev"},{"issue":"2","key":"11_CR67","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvn116","volume":"79","author":"RW Schwenk","year":"2008","unstructured":"Schwenk RW, Luiken JJFP, Bonen A, Glatz JFC. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc Res. 2008;79(2):249\u201358.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"11_CR68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0008-6363(99)00263-1","volume":"45","author":"GJ Vusse van der","year":"2000","unstructured":"van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000;45(2):279\u201393.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"11_CR69","doi-asserted-by":"crossref","first-page":"H1585","DOI":"10.1152\/ajpheart.00599.2009","volume":"297","author":"DJ Chess","year":"2009","unstructured":"Chess DJ, Khairallah RJ, O\u2019Shea KM, Xu W, Stanley WC. A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload. Am J Physiol Heart Circ Physiol. 2009;297(5):H1585\u201393.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"11_CR70","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.HYP.0000248430.26229.0f","volume":"48","author":"IC Okere","year":"2006","unstructured":"Okere IC, Young ME, McElfresh TA, Chess DJ, Sharov VG, Sabbah HN, et al. Low carbohydrate\/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertens (Dallas, Tex 1979). 2006;48(6):1116\u201323.","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"3","key":"11_CR71","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cvr\/cvp132","volume":"83","author":"AD Hafstad","year":"2009","unstructured":"Hafstad AD, Khalid AM, Hagve M, Lund T, Larsen TS, Severson DL, et al. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss. Cardiovasc Res. 2009;83(3):519\u201326.","journal-title":"Cardiovasc Res"},{"issue":"19","key":"11_CR72","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1161\/CIRCULATIONAHA.107.670588","volume":"115","author":"BN Finck","year":"2007","unstructured":"Finck BN, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation. 2007;115(19):2540\u20138.","journal-title":"Circulation"},{"issue":"48","key":"11_CR73","doi-asserted-by":"crossref","first-page":"44390","DOI":"10.1074\/jbc.M103826200","volume":"276","author":"ME Young","year":"2001","unstructured":"Young ME, Laws FA, Goodwin GW, Taegtmeyer H. Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J Biol Chem. 2001;276(48):44390\u20135.","journal-title":"J Biol Chem"},{"issue":"8","key":"11_CR74","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.RES.0000264104.25265.b6","volume":"100","author":"J Yang","year":"2007","unstructured":"Yang J, Sambandam N, Han X, Gross RW, Courtois M, Kovacs A, et al. CD36 deficiency rescues lipotoxic cardiomyopathy. Circ Res. 2007;100(8):1208\u201317.","journal-title":"Circ Res"},{"issue":"3","key":"11_CR75","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/HYPERTENSIONAHA.107.092403","volume":"50","author":"NK Lebrasseur","year":"2007","unstructured":"Lebrasseur NK, Duhaney T-AS, De Silva DS, Cui L, Ip PC, Joseph L, et al. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension. Hypertens (Dallas, Tex 1979). 2007;50(3):489\u201396.","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"6","key":"11_CR76","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/FJC.0b013e3180544540","volume":"49","author":"F Brigadeau","year":"2007","unstructured":"Brigadeau F, Gel\u00e9 P, Wibaux M, Marqui\u00e9 C, Martin-Nizard F, Torpier G, et al. The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy. J Cardiovasc Pharmacol. 2007;49(6):408\u201315.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"11_CR77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.106.116871","volume":"321","author":"V Labinskyy","year":"2007","unstructured":"Labinskyy V, Bellomo M, Chandler MP, Young ME, Lionetti V, Qanud K, et al. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure. J Pharmacol Exp Ther. 2007;321(1):165\u201371.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"11_CR78","doi-asserted-by":"crossref","first-page":"H1899","DOI":"10.1152\/ajpheart.01014.2005","volume":"290","author":"EE Morgan","year":"2006","unstructured":"Morgan EE, Rennison JH, Young ME, McElfresh TA, Kung TA, Tserng K-Y, et al. Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure. Am J Physiol Heart Circ Physiol. 2006;290(5):H1899\u2013904.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"11_CR79","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng0797-226","volume":"16","author":"BH Graham","year":"1997","unstructured":"Graham BH, Waymire KG, Cottrell B, Trounce IA, MacGregor GR, Wallace DC. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart\/muscle isoform of the adenine nucleotide translocator. Nat Genet. 1997;16(3):226\u201334.","journal-title":"Nat Genet"},{"issue":"3","key":"11_CR80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.106.643296","volume":"115","author":"T Walther","year":"2007","unstructured":"Walther T, Tsch\u00f6pe C, Sterner-Kock A, Westermann D, Heringer-Walther S, Riad A, et al. Accelerated mitochondrial adenosine diphosphate\/adenosine triphosphate transport improves hypertension-induced heart disease. Circulation. 2007;115(3):333\u201344.","journal-title":"Circulation"},{"issue":"2","key":"11_CR81","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","volume":"95","author":"JS Ingwall","year":"2004","unstructured":"Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res. 2004;95(2):135\u201345.","journal-title":"Circ Res"},{"issue":"11","key":"11_CR82","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S. The failing heart--an engine out of fuel. N Engl J Med. 2007;356(11):1140\u201351.","journal-title":"N Engl J Med"},{"issue":"1","key":"11_CR83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman B. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. PubMed \u2013 NCBICell. 1999;98(1):115\u201324.","journal-title":"Cell"},{"issue":"6","key":"11_CR84","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","volume":"92","author":"P Puigserver","year":"1998","unstructured":"Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman B. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92(6):829\u201339.","journal-title":"Cell"},{"issue":"1","key":"11_CR85","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/geno.1999.5977","volume":"62","author":"H Esterbauer","year":"1999","unstructured":"Esterbauer H, Oberkofler H, Krempler F, Patsch W. Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization\u2026. PubMed \u2013 NCBIGenomics. 1999;62(1):98\u2013102.","journal-title":"Genomics"},{"issue":"3","key":"11_CR86","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1074\/jbc.C100631200","volume":"277","author":"J Lin","year":"2002","unstructured":"Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem. 2002;277(3):1645\u20138.","journal-title":"J Biol Chem"},{"issue":"11","key":"11_CR87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040369","volume":"4","author":"CJ Lelliott","year":"2006","unstructured":"Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M, et al. Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol. 2006;4(11):e369.","journal-title":"PLoS Biol"},{"issue":"26","key":"11_CR88","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1073\/pnas.0603615103","volume":"103","author":"Z Arany","year":"2006","unstructured":"Arany Z, Novikov M, Chin S, Ma Y, Rosenzweig A, Spiegelman BM. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci U S A. 2006;103(26):10086\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 2","key":"11_CR89","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1113\/jphysiol.2003.045104","volume":"551","author":"A Garnier","year":"2003","unstructured":"Garnier A, Fortin D, Delom\u00e9nie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol. 2003;551(Pt 2):491\u2013501.","journal-title":"J Physiol"},{"issue":"7","key":"11_CR90","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/CIRCRESAHA.111.243964","volume":"109","author":"C Riehle","year":"2011","unstructured":"Riehle C, Wende AR, Zaha VG, Pires KM, Wayment B, Olsen C, et al. PGC-1\u03b2 deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ Res. 2011;109(7):783\u201393.","journal-title":"Circ Res"},{"issue":"4","key":"11_CR91","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1440-1681.2002.03655.x","volume":"29","author":"JJ Lehman","year":"2002","unstructured":"Lehman JJ, Kelly DP. Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clin Exp Pharmacol Physiol. 2002;29(4):339\u201345.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"11_CR92","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","volume":"4","author":"Z Arany","year":"2005","unstructured":"Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, Rybkin II, Shelton JM, Manieri M, Cinti S, Schoen FJ, Bassel-Duby R, Rosenzweig A, Ingwall JSSB. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. PubMed \u2013 NCBICell Metab. 2005;4:259\u201371.","journal-title":"Cell Metab"},{"issue":"4","key":"11_CR93","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","volume":"3","author":"TC Leone","year":"2005","unstructured":"Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 2005;3(4):e101.","journal-title":"PLoS Biol"},{"issue":"5","key":"11_CR94","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.trsl.2015.06.003","volume":"166","author":"XP Liu","year":"2015","unstructured":"Liu XP, Gao H, Huang XY, Chen YF, Feng XJ, He YH, Li ZM, Liu PQ. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway. Transl Res. 2015;166(5):459\u201373.","journal-title":"Transl Res"},{"issue":"14","key":"11_CR95","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1101\/gad.1661708","volume":"22","author":"L Lai","year":"2008","unstructured":"Lai L, Leone TC, Zechner C, Schaeffer PJ, Kelly SM, Flanagan DP, et al. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev. 2008;22(14):1948\u201361.","journal-title":"Genes Dev"},{"issue":"43","key":"11_CR96","doi-asserted-by":"crossref","first-page":"40265","DOI":"10.1074\/jbc.M206324200","volume":"277","author":"JM Huss","year":"2002","unstructured":"Huss JM, Kopp RP, Kelly DP. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J Biol Chem. 2002;277(43):40265\u201374.","journal-title":"J Biol Chem"},{"issue":"7","key":"11_CR97","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI10268","volume":"106","author":"JJ Lehman","year":"2000","unstructured":"Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000;106(7):847\u201356.","journal-title":"J Clin Invest"},{"issue":"4","key":"11_CR98","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.RES.0000117088.36577.EB","volume":"94","author":"LK Russell","year":"2004","unstructured":"Russell LK, Mansfield CM, Lehman JJ, Kovacs A, Courtois M, Saffitz JE, et al. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res. 2004;94(4):525\u201333.","journal-title":"Circ Res"},{"issue":"5","key":"11_CR99","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","volume":"20","author":"RB Vega","year":"2000","unstructured":"Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol. 2000;20(5):1868\u201376.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"11_CR100","doi-asserted-by":"crossref","first-page":"H1307","DOI":"10.1152\/ajpheart.00280.2014","volume":"307","author":"G Karamanlidis","year":"2014","unstructured":"Karamanlidis G, Garcia-Menendez L, Kolwicz SC, Lee CF, Tian R. Promoting PGC-1\u03b1-driven mitochondrial biogenesis is detrimental in pressure-overloaded mouse hearts. Am J Physiol Heart Circ Physiol. 2014;307(9):H1307\u201316.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"11_CR101","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","volume":"94","author":"MN Sack","year":"1996","unstructured":"Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996;94(11):2837\u201342.","journal-title":"Circulation"},{"issue":"4","key":"11_CR102","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/HYPERTENSIONAHA.111.174128","volume":"58","author":"X Hu","year":"2011","unstructured":"Hu X, Xu X, Lu Z, Zhang P, Fassett J, Zhang Y, et al. AMP activated protein kinase-\u03b12 regulates expression of estrogen-related receptor-\u03b1, a metabolic transcription factor related to heart failure development. Hypertens (Dallas, Tex 1979). 2011;58(4):696\u2013703.","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"35","key":"11_CR103","doi-asserted-by":"crossref","first-page":"15565","DOI":"10.1073\/pnas.1002178107","volume":"107","author":"J Kuroda","year":"2010","unstructured":"Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A. 2010;107(35):15565\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"11_CR104","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI200317700","volume":"112","author":"M Yamamoto","year":"2003","unstructured":"Yamamoto M, Yang G, Hong C, Liu J, Holle E, Yu X, et al. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest. 2003;112(9):1395\u2013406.","journal-title":"J Clin Invest"},{"issue":"6","key":"11_CR105","doi-asserted-by":"crossref","first-page":"H651","DOI":"10.1152\/ajpheart.00638.2014","volume":"308","author":"DM Yancey","year":"2015","unstructured":"Yancey DM, Guichard JL, Ahmed MI, Zhou L, Murphy MP, Johnson MS, et al. Cardiomyocyte mitochondrial oxidative stress and cytoskeletal breakdown in the heart with a primary volume overload. Am J Physiol Heart Circ Physiol. 2015;308(6):H651\u201363.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"21","key":"11_CR106","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1161\/CIRCULATIONAHA.108.822403","volume":"119","author":"D-F Dai","year":"2009","unstructured":"Dai D-F, Santana LF, Vermulst M, Tomazela DM, Emond MJ, MacCoss MJ, et al. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation. 2009;119(21):2789\u201397.","journal-title":"Circulation"},{"issue":"2","key":"11_CR107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.RES.85.2.147","volume":"85","author":"DA Siwik","year":"1999","unstructured":"Siwik DA, Tzortzis JD, Pimental DR, Chang DL, Pagano PJ, Singh K, et al. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res. 1999;85(2):147\u201353.","journal-title":"Circ Res"},{"issue":"1","key":"11_CR108","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/bbrc.2001.4744","volume":"283","author":"NL Shih","year":"2001","unstructured":"Shih NL, Cheng TH, Loh SH, Cheng PY, Wang DL, Chen YS, et al. Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene expression via Ras\/Raf\/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes. Biochem Biophys Res Commun. 2001;283(1):143\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"11_CR109","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/FJC.0000000000000210","volume":"65","author":"FR Lemos Caldas","year":"2015","unstructured":"Lemos Caldas FR, Rocha Leite IM, Tavarez Filgueiras AB, de Figueiredo J\u00fanior IL, Gomes Marques de Sousa TA, Martins PR, et al. Mitochondrial ATP-sensitive potassium channel opening inhibits isoproterenol-induced cardiac hypertrophy by preventing oxidative damage. J Cardiovasc Pharmacol. 2015;65(4):393\u20137.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"11_CR110","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/molecules18021383","volume":"18","author":"H Koyama","year":"2013","unstructured":"Koyama H, Nojiri H, Kawakami S, Sunagawa T, Shirasawa T, Shimizu T. Antioxidants improve the phenotypes of dilated cardiomyopathy and muscle fatigue in mitochondrial superoxide dismutase-deficient mice. Molecules. 2013;18(2):1383\u201393.","journal-title":"Molecules"},{"issue":"6","key":"11_CR111","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","volume":"301","author":"H Tsutsui","year":"2011","unstructured":"Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 2011;301(6):H2181\u201390.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"11_CR112","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cbf.1449","volume":"26","author":"IK Adiga","year":"2008","unstructured":"Adiga IK, Nair RR. Multiple signaling pathways coordinately mediate reactive oxygen species dependent cardiomyocyte hypertrophy. Cell Biochem Funct. 2008;26(3):346\u201351.","journal-title":"Cell Biochem Funct"},{"issue":"5","key":"11_CR113","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1582-4934.2008.00620.x","volume":"13","author":"J Cai","year":"2009","unstructured":"Cai J, Yi F-F, Bian Z-Y, Shen D-F, Yang L, Yan L, et al. Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1\/2 signalling pathway. J Cell Mol Med. 2009;13(5):909\u201325.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"11_CR114","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","volume":"133","author":"JR Erickson","year":"2008","unstructured":"Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O\u2019Donnell SE, Aykin-Burns N, Zimmerman MC, Zimmerman K, Ham AJ, Weiss RM, Spitz DR, Shea MA, Colbran RJ, Mohler PJ, Anderson M. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell. 2008;133(3):462\u201374.","journal-title":"Cell"},{"issue":"5","key":"11_CR115","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCRESAHA.108.186288","volume":"104","author":"J Guo","year":"2009","unstructured":"Guo J, Gertsberg Z, Ozgen N, Steinberg SF. p66Shc links alpha1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphorylation pathway in cardiomyocytes. Circ Res. 2009;104(5):660\u20139.","journal-title":"Circ Res"},{"issue":"4","key":"11_CR116","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng1295-376","volume":"11","author":"Y Li","year":"1995","unstructured":"Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995;11(4):376\u201381.","journal-title":"Nat Genet"},{"issue":"1","key":"11_CR117","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cardiores.2004.08.013","volume":"65","author":"G-X Zhang","year":"2005","unstructured":"Zhang G-X, Kimura S, Nishiyama A, Shokoji T, Rahman M, Yao L, et al. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res. 2005;65(1):230\u20138.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"11_CR118","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3181\/0707-RM-206","volume":"233","author":"X-J Zou","year":"2008","unstructured":"Zou X-J, Yang L, Yao S-L. Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro. Exp Biol Med (Maywood). 2008;233(2):200\u20138.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"10","key":"11_CR119","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.freeradbiomed.2006.01.005","volume":"40","author":"H-L Li","year":"2006","unstructured":"Li H-L, Huang Y, Zhang C-N, Liu G, Wei Y-S, Wang A-B, et al. Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med. 2006;40(10):1756\u201375.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"11_CR120","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yjmcc.2011.01.012","volume":"51","author":"ME Anderson","year":"2011","unstructured":"Anderson ME, Brown JHBD. CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol. 2011;51(4):468\u201373.","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"11_CR121","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.107.169755","volume":"102","author":"J Bossuyt","year":"2008","unstructured":"Bossuyt J, Helmstadter K, Wu X, Clements-Jewery H, Haworth RS, Avkiran M, et al. Ca2+\/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure. Circ Res. 2008;102(6):695\u2013702.","journal-title":"Circ Res"},{"issue":"1","key":"11_CR122","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000197782.21444.8f","volume":"98","author":"J Backs","year":"2006","unstructured":"Backs J, Olson EN. Control of cardiac growth by histone acetylation\/deacetylation. Circ Res. 2006;98(1):15\u201324.","journal-title":"Circ Res"},{"issue":"6","key":"11_CR123","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cell.2008.04.041","volume":"133","author":"T Ago","year":"2008","unstructured":"Ago T, Liu T, Zhai P, Chen W, Li H, Molkentin JD, et al. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell. 2008;133(6):978\u201393.","journal-title":"Cell"},{"issue":"7","key":"11_CR124","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.109.213116","volume":"106","author":"T Ago","year":"2010","unstructured":"Ago T, Kuroda J, Pain J, Fu C, Li H, Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res. 2010;106(7):1253\u201364.","journal-title":"Circ Res"},{"issue":"3","key":"11_CR125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cellsig.2015.11.013","volume":"28","author":"T Theccanat","year":"2016","unstructured":"Theccanat T, Philip JL, Razzaque AM, Ludmer N, Li J, Xu X, et al. Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; the role of NADPH oxidase 4. Cell Signal. 2016;28(3):190\u2013203.","journal-title":"Cell Signal"},{"key":"11_CR126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.bi.64.070195.000525","volume":"64","author":"I Fridovich","year":"1995","unstructured":"Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 1995;64:97\u2013112.","journal-title":"Annu Rev Biochem"},{"issue":"3\u20134","key":"11_CR127","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0891-5849(98)00216-0","volume":"26","author":"AJ Kowaltowski","year":"1999","unstructured":"Kowaltowski AJ, Vercesi A. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med. 1999;26(3\u20134):463\u201371.","journal-title":"Free Radic Biol Med"},{"issue":"32","key":"11_CR128","doi-asserted-by":"crossref","first-page":"22028","DOI":"10.1016\/S0021-9258(18)54740-2","volume":"266","author":"R Radi","year":"1991","unstructured":"Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, Freeman BA. Detection of catalase in rat heart mitochondria. J Biol Chem. 1991;266(32):22028\u201334.","journal-title":"J Biol Chem"},{"issue":"1","key":"11_CR129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/abbi.1997.9901","volume":"340","author":"RS Esworthy","year":"1997","unstructured":"Esworthy RS, Ho YS, Chu F. The Gpx1 gene encodes mitochondrial glutathione peroxidase in the mouse liver. Arch Biochem Biophys. 1997;340(1):59\u201363.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"11_CR130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1432-1033.1997.t01-1-00052.x","volume":"249","author":"S Watabe","year":"1997","unstructured":"Watabe S, Hiroi T, Yamamoto Y, Fujioka Y, Hasegawa H, Yago N, et al. SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur J Biochem. 1997;249(1):52\u201360.","journal-title":"Eur J Biochem"},{"issue":"3","key":"11_CR131","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.mca.0000236285.71683.b6","volume":"18","author":"J Cho","year":"2007","unstructured":"Cho J, Won K, Wu D, Soong Y, Liu S, Szeto HH, et al. Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron Artery Dis. 2007;18(3):215\u201320.","journal-title":"Coron Artery Dis"},{"issue":"4","key":"11_CR132","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ahj.2012.12.008","volume":"165","author":"AK Chakrabarti","year":"2013","unstructured":"Chakrabarti AK, Feeney K, Abueg C, Brown DA, Czyz E, Tendera M, Janosi A, Giugliano RP, Kloner RA, Weaver WD, Bode C, Godlewski J, Merkely B, Gibson. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction. Am Heart J. 2013;165(4):509\u201314.","journal-title":"Am Heart J"},{"issue":"1","key":"11_CR133","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2010.12.044","volume":"58","author":"D-F Dai","year":"2011","unstructured":"Dai D-F, Chen T, Szeto H, Nieves-Cintr\u00f3n M, Kutyavin V, Santana LF, et al. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol. 2011;58(1):73\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"11_CR134","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-3565(24)29351-4","volume":"298","author":"HH Szeto","year":"2001","unstructured":"Szeto HH, Lovelace JL, Fridland G, Soong Y, Fasolo J, Wu D, et al. In vivo pharmacokinetics of selective mu-opioid peptide agonists. J Pharmacol Exp Ther. 2001;298(1):57\u201361.","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.lfs.2015.09.022","volume":"141","author":"J Shi","year":"2015","unstructured":"Shi J, Dai W, Hale SL, Brown DA, Wang M, Han X, et al. Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart. Life Sci. 2015;141:170\u20138.","journal-title":"Life Sci"},{"issue":"3","key":"11_CR136","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/ars.2007.1892","volume":"10","author":"HH Szeto","year":"2008","unstructured":"Szeto HH. Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal. 2008;10(3):601\u201319.","journal-title":"Antioxid Redox Signal"},{"issue":"33","key":"11_CR137","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","volume":"279","author":"K Zhao","year":"2004","unstructured":"Zhao K, Zhao G-M, Wu D, Soong Y, Birk AV, Schiller PW, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem. 2004;279(33):34682\u201390.","journal-title":"J Biol Chem"},{"issue":"2","key":"11_CR138","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/HYPERTENSIONAHA.109.130351","volume":"54","author":"D Graham","year":"2009","unstructured":"Graham D, Huynh NN, Hamilton CA, Beattie E, Smith RAJ, Cochem\u00e9 HM, et al. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension. 2009;54(2):322\u20138.","journal-title":"Hypertension"},{"issue":"3","key":"11_CR139","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/HJH.0000000000000054","volume":"32","author":"J McLachlan","year":"2014","unstructured":"McLachlan J, Beattie E, Murphy MP, Koh-Tan CHH, Olson E, Beattie W, et al. Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular function. J Hypertens. 2014;32(3):555\u201364.","journal-title":"J Hypertens"},{"key":"11_CR140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","volume":"47","author":"MP Murphy","year":"2007","unstructured":"Murphy MP, Smith RAJ. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol. 2007;47:629\u201356.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"11_CR141","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","volume":"1201","author":"RAJ Smith","year":"2010","unstructured":"Smith RAJ, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci. 2010;1201:96\u2013103.","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"11_CR142","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","volume":"108","author":"D-F Dai","year":"2011","unstructured":"Dai D-F, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintr\u00f3n M, Chen T, et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res. 2011;108(7):837\u201346.","journal-title":"Circ Res"},{"issue":"3","key":"11_CR143","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/cvr\/cvp092","volume":"82","author":"T Loch","year":"2009","unstructured":"Loch T, Vakhrusheva O, Piotrowska I, Ziolkowski W, Ebelt H, Braun T, et al. Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice. Cardiovasc Res. 2009;82(3):448\u201357.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"11_CR144","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1089\/ars.2011.3969","volume":"15","author":"RAJ Smith","year":"2011","unstructured":"Smith RAJ, Hartley RC, Murphy MP. Mitochondria-targeted small molecule therapeutics and probes. Antioxid Redox Signal. 2011;15(12):3021\u201338.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"11_CR145","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.yjmcc.2004.07.002","volume":"37","author":"Y Xia","year":"2004","unstructured":"Xia Y, Rajapurohitam V, Cook MA, Karmazyn M. Inhibition of phenylephrine induced hypertrophy in rat neonatal cardiomyocytes by the mitochondrial KATP channel opener diazoxide. J Mol Cell Cardiol. 2004;37(5):1063\u20137.","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"11_CR146","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.freeradbiomed.2007.01.001","volume":"42","author":"HTF Facundo","year":"2007","unstructured":"Facundo HTF, de Paula JG, Kowaltowski AJ. Mitochondrial ATP-sensitive K+ channels are redox-sensitive pathways that control reactive oxygen species production. Free Radic Biol Med. 2007;42(7):1039\u201348.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"11_CR147","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.freeradbiomed.2005.08.041","volume":"40","author":"HTF Facundo","year":"2006","unstructured":"Facundo HTF, Carreira RS, de Paula JG, Santos CCX, Ferranti R, Laurindo FRM, et al. Ischemic preconditioning requires increases in reactive oxygen release independent of mitochondrial K+ channel activity. Free Radic Biol Med. 2006;40(3):469\u201379.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"11_CR148","doi-asserted-by":"crossref","first-page":"H2067","DOI":"10.1152\/ajpheart.00272.2006","volume":"291","author":"A Andrukhiv","year":"2006","unstructured":"Andrukhiv A, Costa AD, West IC, Garlid KD. Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol. 2006;291(5):H2067\u201374.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"11_CR149","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10863-005-4130-1","volume":"37","author":"HTF Facundo","year":"2005","unstructured":"Facundo HTF, de Paula JG, Kowaltowski AJ. Mitochondrial ATP-sensitive K+ channels prevent oxidative stress, permeability transition and cell death. J Bioenerg Biomembr. 2005;37(2):75\u201382.","journal-title":"J Bioenerg Biomembr"},{"issue":"5","key":"11_CR150","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1476-5381.2010.00960.x","volume":"161","author":"G Gonz\u00e1lez","year":"2010","unstructured":"Gonz\u00e1lez G, Zald\u00edvar D, Carrillo E, Hern\u00e1ndez A, Garc\u00eda M, S\u00e1nchez J. Pharmacological preconditioning by diazoxide downregulates cardiac L-type Ca(2+) channels. Br J Pharmacol. 2010;161(5):1172\u201385.","journal-title":"Br J Pharmacol"},{"issue":"Pt 1","key":"11_CR151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2003.055095","volume":"555","author":"R Ventura-Clapier","year":"2004","unstructured":"Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol. 2004;555(Pt 1):1\u201313.","journal-title":"J Physiol"},{"issue":"3","key":"11_CR152","doi-asserted-by":"crossref","first-page":"H665","DOI":"10.1152\/ajpheart.00467.2011","volume":"302","author":"M Izem-Meziane","year":"2012","unstructured":"Izem-Meziane M, Djerdjouri B, Rimbaud S, Caffin F, Fortin D, Garnier A, et al. Catecholamine-induced cardiac mitochondrial dysfunction and mPTP opening: protective effect of curcumin. Am J Physiol Heart Circ Physiol. 2012;302(3):H665\u201374.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"18","key":"11_CR153","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.108.835389","volume":"119","author":"G Michels","year":"2009","unstructured":"Michels G, Khan IF, Endres-Becker J, Rottlaender D, Herzig S, Ruhparwar A, et al. Regulation of the human cardiac mitochondrial Ca2+ uptake by 2 different voltage-gated Ca2+ channels. Circulation. 2009;119(18):2435\u201343.","journal-title":"Circulation"},{"issue":"1\u20134","key":"11_CR154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000103747","volume":"20","author":"S Javadov","year":"2007","unstructured":"Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem. 2007;20(1\u20134):1\u201322.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"11_CR155","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.yjmcc.2006.08.117","volume":"41","author":"M Marcil","year":"2006","unstructured":"Marcil M, Ascah A, Matas J, Belanger S, Deschepper C, Burelle Y. Compensated volume overload increases the vulnerability of heart mitochondria without affecting their functions in the absence of stress. J Mol Cell Cardiol. 2006;41(6):998\u20131009.","journal-title":"J Mol Cell Cardiol"},{"key":"11_CR156","doi-asserted-by":"crossref","unstructured":"Xie W, Santulli G, Reiken SR, Yuan Q, Osborne BW, Chen BX, Marks AR. Mitochondrial oxidative stress promotes atrial fibrillation. Sci Rep. 2015;5:11427.","DOI":"10.1038\/srep11427"},{"key":"11_CR157","doi-asserted-by":"crossref","unstructured":"Xie W, Santulli G, Guo X, Gao M, Chen BX, Marks AR. Imaging atrial arrhythmic intracellular calcium in intact heart. J Mol Cell Cardiol. 2013;64:120\u20133.","DOI":"10.1016\/j.yjmcc.2013.09.003"},{"issue":"7033","key":"11_CR158","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nature03317","volume":"434","author":"T Nakagawa","year":"2005","unstructured":"Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature. 2005;434(7033):652\u20138.","journal-title":"Nature"},{"issue":"7033","key":"11_CR159","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature03434","volume":"434","author":"CP Baines","year":"2005","unstructured":"Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 2005;434(7033):658\u201362.","journal-title":"Nature"},{"issue":"3","key":"11_CR160","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.yjmcc.2008.10.020","volume":"46","author":"J Matas","year":"2009","unstructured":"Matas J, Young NT, Bourcier-Lucas C, Ascah A, Marcil M, Deschepper CF, Burelle Y. Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy. J Mol Cell Cardiol. 2009;46(3):420\u201330.","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"11_CR161","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI31060","volume":"117","author":"H Nakayama","year":"2007","unstructured":"Nakayama H, Chen X, Baines CP, Klevitsky R, Zhang X, Zhang H, et al. Ca2\u00b1 and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest. 2007;117(9):2431\u201344.","journal-title":"J Clin Invest"},{"issue":"3","key":"11_CR162","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1124\/jpet.105.100107","volume":"317","author":"S Javadov","year":"2006","unstructured":"Javadov S, Baetz D, Rajapurohitam V, Zeidan A, Kirshenbaum LA, Karmazyn M. Antihypertrophic effect of Na+\/H+ exchanger isoform 1 inhibition is mediated by reduced mitogen-activated protein kinase activation secondary to improved mitochondrial integrity and decreased generation of mitochondrial-derived reactive oxygen species. J Pharmacol Exp Ther. 2006;317(3):1036\u201343.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"11_CR163","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.bbrc.2006.04.011","volume":"344","author":"J Shao","year":"2006","unstructured":"Shao J, Iwashita N, Ikeda F, Ogihara T, Uchida T, Shimizu T, Uchino H, Hirose T, Kawamori R, Watada H. Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db\/db mice. PubMed \u2013 NCBIBiochem Biophys Res Commun. 2006;344(4):1224\u201333.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"11_CR164","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/CT:1:3:205","volume":"1","author":"PJ Oliveira","year":"2001","unstructured":"Oliveira PJ, Rolo AP, Palmeira CM, Moreno AJ. Carvedilol reduces mitochondrial damage induced by hypoxanthine\/xanthine oxidase: relevance to hypoxia\/reoxygenation injury. Cardiovasc Toxicol. 2001;1(3):205\u201313.","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"11_CR165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1385\/CT:4:1:11","volume":"4","author":"PJ Oliveira","year":"2004","unstructured":"Oliveira PJ, Esteves T, Rolo AP, Palmeira CM, Moreno AJM. Carvedilol inhibits the mitochondrial permeability transition by an antioxidant mechanism. Cardiovasc Toxicol. 2004;4(1):11\u201320.","journal-title":"Cardiovasc Toxicol"},{"issue":"2\u20133","key":"11_CR166","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000103384","volume":"80","author":"FC Barone","year":"2007","unstructured":"Barone FC, Willette RN, Nelson AH, Ohlstein EH, Brooks DP, Coatney RW. Carvedilol prevents and reverses hypertrophy-induced cardiac dysfunction. Pharmacology. 2007;80(2\u20133):166\u201376.","journal-title":"Pharmacology"}],"container-title":["Advances in Experimental Medicine and Biology","Mitochondrial Dynamics in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-55330-6_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T20:39:56Z","timestamp":1750279196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-55330-6_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319553290","9783319553306"],"references-count":166,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-55330-6_11","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}